Literature DB >> 15389911

Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran.

G Toogeh1, R Sharifian, M Lak, R Safaee, A Artoni, F Peyvandi.   

Abstract

Glanzmann thrombasthenia (GT) is a rare autosomal recessive disease characterized by prolonged bleeding time with normal platelet count and morphology. It is caused by the quantitative or qualitative deficiency of the platelet glycoprotein IIb-IIIa. In 382 Iranian patients with GT diagnosed at a single center during the period 1969-2001, consanguinity between parents was 86.6%, in accord with the high frequency of intrafamilial marriages in Iran. Almost all patients had had abnormal mucocutaneous bleeding (epistaxis and gum bleeding); at follow-up, 4/5 of the patients had been transfused at least once to control hemorrhagic episodes. As expected, almost all the patients had a normal platelet count while the leukocyte count was increased in 19.3%. Among women, an unexpected low rate of pregnancies was observed. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389911     DOI: 10.1002/ajh.20159

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  16 in total

1.  The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.

Authors:  Giovanni Di Minno; Rainer B Zotz; Roseline d'Oiron; Niels Bindslev; Matteo Nicola Dario Di Minno; Man-Chiu Poon
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

2.  The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.

Authors:  Man-Chiu Poon; Roseline d'Oiron; Rainer B Zotz; Niels Bindslev; Matteo Nicola Dario Di Minno; Giovanni Di Minno
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

3.  Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia.

Authors:  Paola Giordano; Giuseppe Lassandro; Riccardina Tesse; Stefania Longo; Federica Valente; Anna Rita Cappiello; Antonio Coppola
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

4.  Clinical and molecular insights into Glanzmann's thrombasthenia in China.

Authors:  L Zhou; M Jiang; H Shen; T You; Z Ding; Q Cui; Z Ma; F Yang; Z Xie; H Shi; J Su; L Cao; J Lin; J Yin; L Dai; H Wang; Z Wang; Z Yu; C Ruan; L Xia
Journal:  Clin Genet       Date:  2018-05-22       Impact factor: 4.438

5.  Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel.

Authors:  Justyne E Ross; Bing M Zhang; Kristy Lee; Shruthi Mohan; Brian R Branchford; Paul Bray; Stefanie N Dugan; Kathleen Freson; Paula G Heller; Walter H A Kahr; Michele P Lambert; Lori Luchtman-Jones; Minjie Luo; Juliana Perez Botero; Matthew T Rondina; Gabriella Ryan; Sarah Westbury; Wolfgang Bergmeier; Jorge Di Paola
Journal:  Blood Adv       Date:  2021-01-26

6.  Haemophilia in the developing countries: the Iranian experience.

Authors:  Peyman Eshghi; Mitra Mahdavi-Mazdeh; Mehran Karimi; Mohammad Aghighi
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

Review 7.  Glanzmann thrombasthenia.

Authors:  Alan T Nurden
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

8.  Screening bleeding disorders in adolescents and young women with menorrhagia.

Authors:  Suar Cakı Kılıç; Nazan Sarper; Emine Zengin; Sema Aylan Gelen
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

9.  Epistaxis as a Common Presenting Symptom of Glanzmann's Thrombasthenia, a Rare Qualitative Platelet Disorder: Illustrative Case Examples.

Authors:  Michael Recht; Meera Chitlur; Derek Lam; Syana Sarnaik; Madhvi Rajpurkar; David L Cooper; Sriya Gunawardena
Journal:  Case Rep Emerg Med       Date:  2017-02-19

10.  [Glanzmann thrombasthenia: about 11 cases].

Authors:  Jean-Louis Ntumba Mukendi; Souad Benkirane; Azlarab Masrar
Journal:  Pan Afr Med J       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.